Percentage return on R&D among large cap biopharma companies 2010-2020

Published by
Matej Mikulic,
Nov 7, 2022
This statistic shows the percentage of return on investment in research and development among large cap biopharmaceutical companies from 2010 to 2020. Within this time period the returns declined from 10.1 percent to 0.7 percent in 2019. 2020 saw a slight increase up to 1.7 percent.

Percentage return on investments in research and development among large cap biopharmaceutical companies from 2010 to 2020

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2021

Region

Worldwide

Survey time period

2010 to 2020

Special properties

12 largest biopharma companies by R&D spending

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Spain "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Spain

Overview

6

International trade

6

Pharmaceutical sales

6

Pharmaceutical expenditure of the National Health System

6

Research and development

6

Company rankings

6

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in PolandPharmaceutical industry in RomaniaPfizerJohnson & JohnsonRoche
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.